Sound Income Strategies’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Sound Income Strategies’s Portfolio NAVB Stock Details NAVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-599	Closed	-$54	–	1419
2023 Q3	$54	Hold	599	–	–	﹤0.01%	1124
2023 Q2	$55	Hold	599	–	–	﹤0.01%	1087
2023 Q1	$156	Hold	599	–	–	﹤0.01%	1036
2022 Q4	$126	Hold	599	–	–	﹤0.01%	965
2022 Q3	$0	Hold	599	–	–	﹤0.01%	1013
2022 Q2	$0	Hold	599	–	–	﹤0.01%	981
2022 Q1	$0	Hold	599	–	–	﹤0.01%	972
2021 Q4	$1K	Hold	599	–	–	﹤0.01%	834
2021 Q3	$1K	Hold	599	–	–	﹤0.01%	817
2021 Q2	$1K	Hold	599	–	–	﹤0.01%	870
2021 Q1	$1.21K	Hold	599	–	–	﹤0.01%	817
2020 Q4	$1K	Hold	599	–	–	﹤0.01%	863
2020 Q3	$2K	Hold	599	–	–	﹤0.01%	701
2020 Q2	$2K	Hold	599	–	–	﹤0.01%	669
2020 Q1	$0	Hold	599	–	–	﹤0.01%	923
2019 Q4	$1K	Hold	599	–	–	﹤0.01%	688
2019 Q3	$0	Hold	599	–	–	﹤0.01%	803
2019 Q2	$0	Hold	599	–	–	﹤0.01%	807
2019 Q1	$2K	Hold	599	–	–	﹤0.01%	580
2018 Q4	$1K	Hold	599	–	–	﹤0.01%	660
2018 Q3	$3K	Hold	599	–	–	﹤0.01%	528
2018 Q2	$3K	Buy	+599	New	+$3.13K	﹤0.01%	488

Other funds holding NAVB

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.28B AUM 38.1% 1-Year Est. Return

Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

Sound Income Strategies's NAVB Position: Q4 2023 in Review

Sound Income Strategies sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q4 2023, closing a stake of 599 shares — an estimated $54 sold.

Sound Income Strategies first reported a position in NAVB in Q2 2018 and held it in 22 quarters. The position peaked at $3K in Q3 2018. 4 funds tracked by Wall St. Rank hold NAVB as of Q4 2023.

Sound Income Strategies reported no remaining Navidea Biopharmaceuticals Inc. position as of Q4 2023 after selling out during the quarter.
Sound Income Strategies sold 599 Navidea Biopharmaceuticals Inc. shares in Q4 2023, an estimated $54.
Sound Income Strategies first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2018 and held it in 22 quarters.
Sound Income Strategies's Navidea Biopharmaceuticals Inc. position peaked at $3K in Q3 2018.
4 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q4 2023.

Based on Sound Income Strategies's 13F filing for Q4 2023, filed 10 Jan 2024.